# Pre-delivery Administration of Azithromycin to Prevent Neonatal Sepsis & Death

> **NCT03199547** · PHASE3 · COMPLETED · sponsor: **London School of Hygiene and Tropical Medicine** · enrollment: 11985 (actual)

## Conditions studied

- Neonatal SEPSIS

## Interventions

- **DRUG:** Azithromycin
- **DRUG:** Placebo Oral Tablet

## Key facts

- **NCT ID:** NCT03199547
- **Lead sponsor:** London School of Hygiene and Tropical Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-21
- **Primary completion:** 2021-05-31
- **Final completion:** 2021-05-31
- **Target enrollment:** 11985 (ACTUAL)
- **Last updated:** 2022-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03199547

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03199547, "Pre-delivery Administration of Azithromycin to Prevent Neonatal Sepsis & Death". Retrieved via AI Analytics 2026-05-21 from https://api.ai-analytics.org/clinical/NCT03199547. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*